World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 71 2269 2084 1099 997 156 29625

Egil Lien publications per year

The chart shows the history of publications by Egil Lien between 1992 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Egil Lien published across 34 years, from 1992 to 2025, averaging 4.7 papers a year. Output peaked at 13 publications in 1999. 3 of the 160 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1992 to 2025. Vertical axis: number of publications, 0 to 13. Peak 13 publications in 1999. 1992: 1 publication 1993: 3 publications 1994: 2 publications 1995: 1 publication 1996: 4 publications 1997: 5 publications 1998: 1 publication 1999: 13 publications 2000: 4 publications 2001: 8 publications 2002: 9 publications 2003: 9 publications 2004: 6 publications 2005: 2 publications 2006: 6 publications 2007: 3 publications 2008: 6 publications 2009: 7 publications 2010: 11 publications 2011: 1 publication 2012: 7 publications 2013: 5 publications 2014: 8 publications 2015: 5 publications 2016: 5 publications 2017: 3 publications 2018: 3 publications 2019: 5 publications 2020: 7 publications 2021: 3 publications 2022: 0 publications 2023: 4 publications 2024: 2 publications 2025: 1 publication
1992 2025

160 publications in total across all disciplines

View publications per year as a table
Egil Lien: publications per year, 1992 to 2025
Year Publications
1992 1
1993 3
1994 2
1995 1
1996 4
1997 5
1998 1
1999 13
2000 4
2001 8
2002 9
2003 9
2004 6
2005 2
2006 6
2007 3
2008 6
2009 7
2010 11
2011 1
2012 7
2013 5
2014 8
2015 5
2016 5
2017 3
2018 3
2019 5
2020 7
2021 3
2022 0
2023 4
2024 2
2025 1
Total 160
Download as CSV

Egil Lien publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Egil Lien sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 152–161 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 156 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189 156
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Egil Lien D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Egil Lien sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 70–71 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199 71
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Egil Lien is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research spans several areas within biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, with a focus on molecular biology and immunology as primary subfields.

Their recent research outputs emphasize mechanisms of immune response, inflammation, and cell death. These include investigations into inflammasome activation, caspase-8 roles, and kinase activities relevant to disease progression and immune regulation.

  • Multiple roles of caspase-8 in cell death, inflammation, and innate immunity (2020), Journal of Leukocyte Biology
  • RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis (2021), Cell Reports
  • RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages (2020), Cell Death and Differentiation
  • Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury (2020), Alcoholism Clinical and Experimental Research
  • MLKL-Driven Inflammasome Activation and Caspase-8 Mediate Inflammatory Cell Death in Influenza A Virus Infection (2023), mBio

Their work is frequently published in journals such as Nature Communications, bioRxiv (Cold Spring Harbor Laboratory), Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, Journal of Leukocyte Biology, and Cell Reports.

Frequent collaborators include:

  • Pontus Ørning
  • Katherine A. Fitzgerald
  • Boyao Zhang
  • Liv Ryan
  • Terje Espevik

Main research topics covered in their studies comprise:

  • Inflammasome and immune disorders
  • Interferon and immune responses
  • Immune response and inflammation
  • Cell death mechanisms and regulation
  • Liver disease diagnosis and treatment
  • Pancreatitis pathology and treatment
  • Endoplasmic reticulum stress and disease

Best Publications

  • NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

    Peter Duewell;Hajime Kono;Katey J. Rayner;Katey J. Rayner;Cherilyn M. Sirois

  • TLR9 signals after translocating from the ER to CpG DNA in the lysosome

    Eicke Latz;Annett Schoenemeyer;Alberto Visintin;Katherine A. Fitzgerald

  • Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2

    Atsutoshi Yoshimura;Egil Lien;Robin R. Ingalls;Elaine Tuomanen

  • TOLL-LIKE RECEPTOR 2 FUNCTIONS AS A PATTERN RECOGNITION RECEPTOR FOR DIVERSE BACTERIAL PRODUCTS

    Egil Lien;Egil Lien;Timothy J. Sellati;Atsutoshi Yoshimura;Trude H. Flo

  • Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis

    Terry K. Means;Shuyan Wang;Egil Lien;Atsutoshi Yoshimura

  • Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death.

    Pontus Orning;Pontus Orning;Dan Weng;Dan Weng;Kristian Starheim;Kristian Starheim;Dmitry Ratner

  • Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide

    Egil Lien;Terry K. Means;Holger Heine;Atsutoshi Yoshimura

  • Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

    Pål Aukrust;Thor Ueland;Egil Lien;Klaus Bendtzen

  • Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction.

    Eicke Latz;Alberto Visintin;Egil Lien;Egil Lien;Katherine A. Fitzgerald

  • Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling

    Karen Bieback;Egil Lien;Ingo M. Klagge;Elita Avota

  • The CD14 Ligands Lipoarabinomannan and Lipopolysaccharide Differ in Their Requirement for Toll-Like Receptors

    Terry K. Means;Egil Lien;Atsutoshi Yoshimura;Shuyan Wang

  • The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury

    Øystein Sandanger;Trine Ranheim;Leif Erik Vinge;Leif Erik Vinge;Marte Bliksøen

  • Inflammatory Response After Open Heart Surgery: Release of Heat-Shock Protein 70 and Signaling Through Toll-Like Receptor-4

    Brit Dybdahl;Alexander Wahba;Egil Lien;Trude H. Flo

  • Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response

    Sara W. Montminy;Naseema N. Khan;Sara C. McGrath;Mitchell J. Walkowicz

  • Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure

    Lars Gullestad;Halfdan Aass;Jan G. Fjeld;Lisbeth Wikeby

  • Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters.

    P Aukrust;N B Liabakk;F Müller;E Lien

  • Innate Immune Recognition of Invasive Bacteria Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice

    Frank C. Gibson;Charlie Hong;Hsin Hua Chou;Hiromichi Yumoto

  • The NLRP12 Inflammasome Recognizes Yersinia pestis

    Gregory I. Vladimer;Dan Weng;Sara W. Montminy Paquette;Sivapriya Kailasan Vanaja

  • Toll-like receptors.

    Egil Lien;Robin R. Ingalls

  • Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line A Point Mutation in a Conserved Region of Md-2 Abolishes Endotoxin-Induced Signaling

    Andra B. Schromm;Egil Lien;Philipp Henneke;Jesse C. Chow

  • Erratum: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals (Nature (2010) 464 (1357-1361))

    Peter Duewell;Hajime Kono;Katey J. Rayner;Cherilyn M. Sirois

Frequent Co-Authors

Terje Espevik
Terje Espevik Norwegian University of Science and Technology
Douglas T. Golenbock
Douglas T. Golenbock University of Massachusetts Chan Medical School
Katherine A. Fitzgerald
Katherine A. Fitzgerald University of Massachusetts Chan Medical School
Pål Aukrust
Pål Aukrust Oslo University Hospital
Stig S. Frøland
Stig S. Frøland University of Oslo
Eicke Latz
Eicke Latz German Rheumatism Research Centre
Arne Yndestad
Arne Yndestad Oslo University Hospital
Fredrik Müller
Fredrik Müller University of Oslo
Thor Ueland
Thor Ueland University of Oslo
Ricardo T. Gazzinelli
Ricardo T. Gazzinelli Universidade Federal de Minas Gerais

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary health science careers can broaden opportunities. Many students consider nursing pathways that offer direct patient care and specialized knowledge in immune-related conditions.

Accelerated programs provide a fast-track option to enter the nursing field. If you already hold a degree, an nurse practitioner accelerated program could be a strategic step toward a higher-level clinical role. These programs focus on efficient learning without compromising essential skills.

For individuals without a nursing background, there are tailored options such as online nursing programs for non nurses. These programs introduce foundational knowledge necessary for nursing careers and offer flexible learning environments.

Furthermore, if quick entry into nursing is a priority, examining accelerated nursing programs or exploring easy lpn programs to get into can be valuable. These options emphasize accessible admission requirements and practical training, ideal for students aiming to join the workforce swiftly.

Best Scientists Citing Egil Lien

Trending Scientists

Recently Published Articles